Literature DB >> 20700634

Association between hepatitis B viral burden in chronic infection and a functional single nucleotide polymorphism of the PDCD1 gene.

Linghua Zheng1, Dongling Li, Fusheng Wang, Hao Wu, Xiaozhu Li, Junliang Fu, Xinyue Chen, Lizhong Wang, Yang Liu, Shengdian Wang.   

Abstract

BACKGROUND: PD-1, encoded by PDCD1, is highly expressed on virus-specific T cells and plays critical roles in modulating anti-virus immune responses in chronic viral infection. It is unknown, however, whether polymorphisms of the PDCD1 are associated with viral clearance during chronic viral infections. METHODOLOGY AND PRINCIPAL
FINDINGS: Here, we used the polymerase chain reaction-restriction fragment length polymorphism method to genotype two single nucleotide polymorphisms (SNPs) of PDCD1 in 502 patients with chronic hepatitis B virus (HBV) infection and 359 healthy controls to determine the association between PDCD1 genotypes and serum viral load as well as the risk of chronic infection. Our results showed that although neither the P7209(C/T) SNP site nor the P8737(A/G) site was associated with the risk of chronic HBV infection, the P7209 (T) allele in intron 4 is significantly associated with lower viral burden in the blood. Using a luciferase reporter assay, we demonstrated that the P7209 (T) allele creates a negative cis-element for gene transcription. CONCLUSIONS AND SIGNIFICANCE: Our data provide the first evidence that PDCD1 polymorphisms is a genetic factor in pathogenesis of chronic viral infection and reveal the functional significance of the P7209 SNP of the PDCD1.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20700634     DOI: 10.1007/s10875-010-9450-1

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.317


  28 in total

1.  Cell-type-dependent activity of the ubiquitous transcription factor USF in cellular proliferation and transcriptional activation.

Authors:  Y Qyang; X Luo; T Lu; P M Ismail; D Krylov; C Vinson; M Sawadogo
Journal:  Mol Cell Biol       Date:  1999-02       Impact factor: 4.272

2.  Programmed death-1 gene polymorphisms in patients with systemic lupus erythematosus in Taiwan.

Authors:  Shu-Chen Wang; Yi-Jing Chen; Tsan-Teng Ou; Cheng-Chin Wu; Wen-Chan Tsai; Hong-Wen Liu; Jeng-Hsien Yen
Journal:  J Clin Immunol       Date:  2006-10-06       Impact factor: 8.317

3.  HLA A2 restricted cytotoxic T lymphocyte responses to multiple hepatitis B surface antigen epitopes during hepatitis B virus infection.

Authors:  R Nayersina; P Fowler; S Guilhot; G Missale; A Cerny; H J Schlicht; A Vitiello; R Chesnut; J L Person; A G Redeker; F V Chisari
Journal:  J Immunol       Date:  1993-05-15       Impact factor: 5.422

4.  Cytotoxic T-lymphocyte antigen 4 gene and recovery from hepatitis B virus infection.

Authors:  Chloe L Thio; Timothy L Mosbruger; Richard A Kaslow; Christopher L Karp; Steffanie A Strathdee; David Vlahov; Stephen J O'Brien; Jacquie Astemborski; David L Thomas
Journal:  J Virol       Date:  2004-10       Impact factor: 5.103

5.  The programmed cell death 1 gene 7209 C>T polymorphism is associated with the risk of systemic lupus erythematosus in the Polish population.

Authors:  M Mostowska; M Wudarski; H Chwalińska-Sadowska; P P Jagodziński
Journal:  Clin Exp Rheumatol       Date:  2008 May-Jun       Impact factor: 4.473

6.  Association of the PD-1.3A allele of the PDCD1 gene in patients with rheumatoid arthritis negative for rheumatoid factor and the shared epitope.

Authors:  Ludmila Prokunina; Leonid Padyukov; Anna Bennet; Ulf de Faire; Björn Wiman; Jonathan Prince; Lars Alfredsson; Lars Klareskog; Marta Alarcón-Riquelme
Journal:  Arthritis Rheum       Date:  2004-06

7.  Association of a programmed death 1 gene polymorphism with the development of rheumatoid arthritis, but not systemic lupus erythematosus.

Authors:  Shih-Chang Lin; Jeng-Hsien Yen; Jaw-Ji Tsai; Wen-Chen Tsai; Tsan-Teng Ou; Hong-Wen Liu; Chung-Jen Chen
Journal:  Arthritis Rheum       Date:  2004-03

8.  Association of a putative regulatory polymorphism in the PD-1 gene with susceptibility to type 1 diabetes.

Authors:  C Nielsen; D Hansen; S Husby; B B Jacobsen; S T Lillevang
Journal:  Tissue Antigens       Date:  2003-12

9.  Programmed death-1 (PD-1) gene polymorphisms lodged in the genetic predispositions of Kawasaki Disease.

Authors:  Jin-Kyong Chun; Dong Won Kang; Byung Won Yoo; Jeon-Soo Shin; Dong Soo Kim
Journal:  Eur J Pediatr       Date:  2009-05-26       Impact factor: 3.183

10.  Cytotoxic T lymphocytes recognize an HLA-A2-restricted epitope within the hepatitis B virus nucleocapsid antigen.

Authors:  A Penna; F V Chisari; A Bertoletti; G Missale; P Fowler; T Giuberti; F Fiaccadori; C Ferrari
Journal:  J Exp Med       Date:  1991-12-01       Impact factor: 14.307

View more
  7 in total

1.  Polymorphisms in programmed death-1 gene are not associated with chronic HBV infection in Chinese patients.

Authors:  Feng Lv; Yu-Feng Gao; Zhen-Huan Zhang; Tian-Chen Zhang; Fa-Ming Pan; Ming-Fang Cui; Shu-Ling Xia; Xu Li; Hua-Fa Yin
Journal:  World J Hepatol       Date:  2011-03-27

Review 2.  Coinhibitory Pathways in the B7-CD28 Ligand-Receptor Family.

Authors:  Frank A Schildberg; Sarah R Klein; Gordon J Freeman; Arlene H Sharpe
Journal:  Immunity       Date:  2016-05-17       Impact factor: 31.745

3.  Genetic polymorphism of HLA-DQ confers susceptibility to hepatitis B virus-related hepatocellular carcinoma: a case-control study in Han population in China.

Authors:  Xia Gao; Wenxuan Liu; Xiaolin Zhang; Longmei Tang; Liqin Wang; Lina Yan; Haitao Yang; Tao Li; Lei Yang; Ning Ma; Dianwu Liu
Journal:  Tumour Biol       Date:  2016-05-21

4.  PDCD1 and PDCD1LG1 polymorphisms affect the susceptibility to multiple myeloma.

Authors:  Tetsuhiro Kasamatsu; Maaya Awata; Rei Ishihara; Yuki Murakami; Nanami Gotoh; Morio Matsumoto; Morio Sawamura; Akihiko Yokohama; Hiroshi Handa; Norifumi Tsukamoto; Takayuki Saitoh; Hirokazu Murakami
Journal:  Clin Exp Med       Date:  2019-10-16       Impact factor: 3.984

5.  Role of GSPT1 and GSPT2 polymorphisms in different outcomes upon Hepatitis B virus infection and prognosis to lamivudine therapy.

Authors:  Wenxuan Liu; Ning Ma; Xia Gao; Wencong Liu; Jinhai Jia; Longmei Tang; Man Li; Lei Yang; Tao Li; Lina Yan; Xiaolin Zhang; Fengxue Yu
Journal:  Biosci Rep       Date:  2019-03-28       Impact factor: 3.840

Review 6.  Immune Checkpoint Molecules-Inherited Variations as Markers for Cancer Risk.

Authors:  Marta Wagner; Monika Jasek; Lidia Karabon
Journal:  Front Immunol       Date:  2021-01-14       Impact factor: 7.561

7.  PDCD1 Polymorphisms May Predict Response to Anti-PD-1 Blockade in Patients With Metastatic Melanoma.

Authors:  Sagun Parakh; Ashan Musafer; Sabrina Paessler; Tom Witkowski; Connie S N Li Wai Suen; Candani S A Tutuka; Matteo S Carlino; Alexander M Menzies; Richard A Scolyer; Jonathan Cebon; Alexander Dobrovic; Georgina V Long; Oliver Klein; Andreas Behren
Journal:  Front Immunol       Date:  2021-06-09       Impact factor: 7.561

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.